These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7861016)

  • 1. Design and implementation of the stavudine parallel-track program.
    Anderson RE; Dunkle LM; Smaldone L; Adler M; Wirtz C; Kriesel D; Cross A; Martin RR
    J Infect Dis; 1995 Mar; 171 Suppl 2():S118-22. PubMed ID: 7861016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-related activity of stavudine in patients infected with human immunodeficiency virus.
    Petersen EA; Ramírez-Ronda CH; Hardy WD; Schwartz R; Sacks HS; Follansbee S; Peterson DM; Cross A; Anderson RE; Dunkle LM
    J Infect Dis; 1995 Mar; 171 Suppl 2():S131-9. PubMed ID: 7861018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection.
    Lea AP; Faulds D
    Drugs; 1996 May; 51(5):846-64. PubMed ID: 8861550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic effects and safety of stavudine: overview of phase I and II clinical trials.
    Skowron G
    J Infect Dis; 1995 Mar; 171 Suppl 2():S113-7. PubMed ID: 7861015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.
    Saag MS; Cahn P; Raffi F; Wolff M; Pearce D; Molina JM; Powderly W; Shaw AL; Mondou E; Hinkle J; Borroto-Esoda K; Quinn JB; Barry DW; Rousseau F;
    JAMA; 2004 Jul; 292(2):180-9. PubMed ID: 15249567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II evaluation of stavudine (d4T) in children with human immunodeficiency virus infection.
    Kline MW; Dunkle LM; Church JA; Goldsmith JC; Harris AT; Federici ME; Schultze ME; Woods L; Loewen DF; Kaul S
    Pediatrics; 1995 Aug; 96(2 Pt 1):247-52. PubMed ID: 7630678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
    Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
    AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of once and twice daily dosing of didanosine in combination with stavudine for the treatment of HIV-1 infection. AI 454-146 Team.
    Monno L; Cargnel A; Soranzo ML; Chirianni A; Ferraro T; Di Stefano M; Angarano G
    Antivir Ther; 1999; 4(4):195-202. PubMed ID: 10723498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature.
    Rossero R; Asmuth DM; Grady JJ; McKinsey DS; Green S; Andron L; Pollard RB
    Int J STD AIDS; 2003 May; 14(5):350-5. PubMed ID: 12803944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of stavudine.
    Rana KZ; Dudley MN
    Clin Pharmacokinet; 1997 Oct; 33(4):276-84. PubMed ID: 9342503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.
    Shafer RW; Smeaton LM; Robbins GK; De Gruttola V; Snyder SW; D'Aquila RT; Johnson VA; Morse GD; Nokta MA; Martinez AI; Gripshover BM; Kaul P; Haubrich R; Swingle M; McCarty SD; Vella S; Hirsch MS; Merigan TC;
    N Engl J Med; 2003 Dec; 349(24):2304-15. PubMed ID: 14668456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term efficacy and safety of stavudine in pretreated HIV-infected patients.
    Villalba N; Soriano V; Gómez-Cano M; Castilla J; Mas A; González-Lahoz J
    Antivir Ther; 1997 Jul; 2(3):185-9. PubMed ID: 11322273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors.
    Schweinsburg BC; Taylor MJ; Alhassoon OM; Gonzalez R; Brown GG; Ellis RJ; Letendre S; Videen JS; McCutchan JA; Patterson TL; Grant I;
    J Neurovirol; 2005 Aug; 11(4):356-64. PubMed ID: 16206458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Didanosine: an updated review of its use in HIV infection.
    Perry CM; Noble S
    Drugs; 1999 Dec; 58(6):1099-135. PubMed ID: 10651392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of stavudine plus didanosine in asymptomatic HIV-infected children with plasma HIV RNA below 50,000 copies per milliliter.
    de Mendoza C; Ramos JT; Ciria L; Fortuny C; García FJ; de José MI; Asensi F; Soriano V
    HIV Clin Trials; 2002; 3(1):9-16. PubMed ID: 11819180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans.
    Wadley AL; Cherry CL; Price P; Kamerman PR
    J Pain Symptom Manage; 2011 Apr; 41(4):700-6. PubMed ID: 21145196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
    Cherry CL; Affandi JS; Imran D; Yunihastuti E; Smyth K; Vanar S; Kamarulzaman A; Price P
    Neurology; 2009 Jul; 73(4):315-20. PubMed ID: 19636052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside reverse transcriptase inhibitor usage and the incidence of peripheral neuropathy in HIV/AIDS patients.
    Dragovic G; Jevtovic D
    Antivir Chem Chemother; 2003 Sep; 14(5):281-4. PubMed ID: 14694991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stavudine, didanosine and nevirapine in antiretroviral-naive HIV-1-infected patients.
    Reliquet V; Ferré V; Hascoet C; Besnier JM; Bellein V; Arvieux C; Molina JM; Breux JP; Zucman D; Rozenbaum W; Allavena C; Raffi F;
    Antivir Ther; 1999; 4 Suppl 3():83-4. PubMed ID: 16021876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.